Inretio · raw details

Ischemic Stroke Treatment · Nir Am · Founded 2017

active Series A ← back to profile

About

Ischemic Stroke Treatment

Inretio develops solutions that address complications during clot retrieval procedures for ischemic stroke treatment.

Identity

NameInretio
Sluginretio
Type / kindstartup
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Iep89QIDA

Status

Statusactive
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtSouth District
HQ cityNir Am
HQ addressNir Am, Israel

Web & social

Websitehttps://www.inretio.co.il
LinkedInhttps://www.linkedin.com/company/68842510

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
treatmentsmedical-devicesstroke

Funding

Total raised$2.5M
Current stageSeries A

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}